Log In
BCIQ
Print this Print this
 

C-82

  Manage Alerts
Collapse Summary General Information
Company Prism Pharma Co. Ltd.
DescriptionBeta catenin/CPB modulator
Molecular Target Beta-catenin (CTNNB1)
Mechanism of ActionBeta-catenin antagonist; CREB-binding protein inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today